BPC-157 (Body Protection Compound-157) is a synthetic peptide comprising 15 amino acids, thus making it a pentadecapeptide
It was first developed in 1991 as a derivative of Body Protection Compound, a peptide naturally found in human gastric juices [1, 2]
Many also mention better focus and steadier mood
Comparison and Clinical Implications Final Verdict: Platelet-Rich Plasma is a Validated Treatment, While Peptide Therapy Requires Further Research While peptide injections show promise in preclinical studies, their role in musculoskeletal treatment remains experimental , with a lack of well-controlled human trials to confirm their efficacy
[DOI] [PubMed] [Google Scholar] 11
These include [6, 34, 39]: Irritation at the site of injection Fatigue Nausea Light-headedness Sweatin g Adverse effects are often attributable to low-grade peptides